ABSTRACT
Cellular migration is a ubiquitous feature that brings brain cells into appropriate spatial relationships over time; and is believed to contribute to the pathology of bipolar disorder (BD). There are also structural differences in BD-brain, demonstrated by multiple imaging studies. We studied the movement patterns of induced pluripotent stem cell (IPSC) derived neural precursor cell (NPC) derived from individuals with BD, in an effort to recapitulate and study anomalies in migration. These individual patients had a severe clinical phenotype, including anomalies in structural brain imaging. We conducted time-lapse analysis and identified abnormal directionality of cellular migration in NPCs derived from these patients. We further studied the whole exome, and NPC transcriptomes of these patients, to investigate the underlying mechanisms of aberrant migration. Whole exome sequencing revealed several rare and deleterious variants in migration-related genes. Transcriptomic analysis showed downregulation of genes that were part of the EGF/ERBB signaling pathway. We suggest that collective, systemic dysregulation may produce the aberrant cellular phenotype; which could contribute to the functional and structural changes in the brain, reported in bipolar disorder.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a grant from the Department of Biotechnology (COE), India funded grants- Targeted generation and interrogation of cellular models and networks in neuro-psychiatric disorders using candidate genes (BT/01/CEIB/11/VI/11/2012) and Accelerating program for discovery in brain disorders using stem cells (BT/PR17316/MED/31/326/2015) (ADBS); the Department of Science and Technology, India funded grants- Imaging-genomics approach to identify molecular markers of Lithium response in Bipolar disorder through the DST-INSPIRE Faculty Fellowship awarded to Dr. Biju Viswanath (Project number 00671, Code: IFA-12-LSBM-44) and SCIENCE& ENGINEERING RESEARCH BOARD (SERB) project Dissecting the biology of lithium response in human induced pluripotent stem cell derived neurons from patients with bipolar affective disorder (FILE NO. ECR/2016/002076).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol has been approved by the ethics committee of the National Institute of Mental Health and Neurosciences, Bengaluru, India (No. NIMHANS/DO/96TH lEC/2015). Clinical protocol for this study conforms to the ethical norms and standards in the Declaration of Helsinki. Committee decision: protocol approved Committee members: 1. Dr. AK Kurpad, Professor of Physiology, NIMHANS; Chair, Ethics committee 2. Mr. AR Patil, Professor, National Law School of India; legal expert on the Ethics committee 3. Dr. Dennis Xavier, Prof. & Head, Dept of Pharmacology, St. John's Medical College 4. Dr. Rajaram Subbian, social scientist on the ethics committee 5. Dr. Pratima Murthy, Dept. of Psychiatry, NIMHANS 6. Dr. Pramod Pal, Dept. of Neurology, NIMHANS 7. Dr. M. Jayaram, Dept of Speech Pathology & Audiology 8. Dr. V. Ravi, Dept. of Neurovirology, NIMHANS 9. Dr. B.N. Gangadhar, Dept. of Psychiatry, NIMHANS
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Available upon request
